404 related articles for article (PubMed ID: 21298845)
1. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.
Paveenkittiporn W; Apisarnthanarak A; Dejsirilert S; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S46-52. PubMed ID: 21298845
[TBL] [Abstract][Full Text] [Related]
2. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore.
Sivalingam SP; Sim SH; Aw LT; Ooi EE
J Antimicrob Chemother; 2006 Nov; 58(5):1102-3. PubMed ID: 16951412
[No Abstract] [Full Text] [Related]
5. Reduced susceptibility of Malaysian clinical isolates of Burkholderia pseudomallei to ciprofloxacin.
Liew FY; Tay ST; Puthucheary SD
Trop Biomed; 2011 Dec; 28(3):646-50. PubMed ID: 22433895
[TBL] [Abstract][Full Text] [Related]
6. Cases of melioidosis in a university teaching hospital in Malaysia.
Raja NS
J Microbiol Immunol Infect; 2008 Apr; 41(2):174-9. PubMed ID: 18473106
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Burkholderia pseudomallei to tigecycline and other antimicrobials.
Sam IC; See KH; Puthucheary SD
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):308-9. PubMed ID: 20356698
[No Abstract] [Full Text] [Related]
9. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N
Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020
[No Abstract] [Full Text] [Related]
10. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination.
Lumbiganon P; Tattawasatra U; Chetchotisakd P; Wongratanacheewin S; Thinkhamrop B
J Med Assoc Thai; 2000 Aug; 83(8):856-60. PubMed ID: 10998837
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501
[TBL] [Abstract][Full Text] [Related]
12. Mycotic aneurysm in Northeast Thailand: the importance of Burkholderia pseudomallei as a causative pathogen.
Anunnatsiri S; Chetchotisakd P; Kularbkaew C
Clin Infect Dis; 2008 Dec; 47(11):1436-9. PubMed ID: 18937581
[TBL] [Abstract][Full Text] [Related]
13. Infectious disease. Racing to defuse a bacterial time bomb.
Stone R
Science; 2007 Aug; 317(5841):1022-4. PubMed ID: 17717162
[No Abstract] [Full Text] [Related]
14. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
Nhung PH; Van VH; Anh NQ; Phuong DM
J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
[TBL] [Abstract][Full Text] [Related]
15. Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory.
Hemarajata P; Baghdadi JD; Hoffman R; Humphries RM
J Clin Microbiol; 2016 Dec; 54(12):2866-2873. PubMed ID: 27654336
[TBL] [Abstract][Full Text] [Related]
16. Isolation rates of Burkholderia pseudomallei among the four regions in Thailand.
Leelarasamee A; Trakulsomboon S; Kusum M; Dejsirilert S
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):107-13. PubMed ID: 9322292
[TBL] [Abstract][Full Text] [Related]
17. Imported melioidosis in Danish travellers: a diagnostic challenge.
Badran S; Pedersen TI; Roed C; Lunding S; Birk N; Vestergaard H; Røder B; Lillelund HK; Kurtzhals JA; Kemp M; Christensen JJ
Scand J Infect Dis; 2010 Jul; 42(6-7):445-9. PubMed ID: 20297927
[TBL] [Abstract][Full Text] [Related]
18. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005.
Dejsirilert S; Suankratay C; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N; Tantisiriwat W
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S68-75. PubMed ID: 21298847
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of melioidosis in the suburbs of Mangalore, S West Coast of India.
Antony B; Pinto H; Dias M; Shetty AK; Scaria B; Kuruvilla T; Boloor R
Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):169-74. PubMed ID: 20578496
[TBL] [Abstract][Full Text] [Related]
20. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
